WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST)

Q1 2025 13F Holders as of 3/31/2025

Type / Class
Equity / Common Stock
Shares outstanding
71.9M
Number of holders
699
Total 13F shares, excl. options
68.8M
Shares change
-658K
Total reported value, excl. options
$15.4B
Value change
-$324M
Put/Call ratio
0.66
Number of buys
350
Number of sells
-369
Price
$223.88

Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q1 2025

842 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q1 2025.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 699 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 68.8M shares of 71.9M outstanding shares and own 95.61% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.23M shares), BlackRock, Inc. (6.93M shares), Bank of New York Mellon Corp (3.38M shares), BROWN ADVISORY INC (3.27M shares), STATE STREET CORP (3.2M shares), Artisan Partners Limited Partnership (2.2M shares), GEODE CAPITAL MANAGEMENT, LLC (1.85M shares), Durable Capital Partners LP (1.57M shares), APG Asset Management N.V. (1.56M shares), and FRANKLIN RESOURCES INC (1.56M shares).
This table shows the top 699 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.